Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients

European Journal of Neurology

Volumn 22, Issue 3, 2015, Pages 540-546

  Reimao S ^a,b   Pita Lobo, P ^a,b   Neutel, D ^a,b   Correia Guedes, L ^a,b   Coelho, M ^a,b   Rosa, M M ^a,b,c   Ferreira, J ^d   Abreu, D ^b   Goncalves N ^b   Morgado, C ^a   Nunes, R G ^d   Campos, J ^a   Ferreira, J J ^a,b,c  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^d UNIVERSITY OF LISBON   (Portugal)

Author keywords

Locus coeruleus; Magnetic resonance imaging; Neuromelanin; Parkinson's disease; Substantia nigra

Indexed keywords

BIOLOGICAL MARKER; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; NEUROMELANIN; MELANIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DISEASE DURATION; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; IMAGE QUALITY; MALE; MESENCEPHALON; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; AGED; LOCUS CERULEUS; METABOLISM; MIDDLE AGED; PROCEDURES; STANDARDS;

AGED; BIOMARKERS; FEMALE; HUMANS; LOCUS COERULEUS; MAGNETIC RESONANCE IMAGING; MALE; MELANINS; MIDDLE AGED; PARKINSON DISEASE; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA;

EID: 84922604940     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12613     Document Type: Article

References (18)

1. Mann DM, Yates PO. Pathological basis for neurotransmitter changes in Parkinson's disease. Neuropathol Appl Neurobiol 1983; 9: 3-19.
2. Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
3. Double KL, Gerlach M, Schünemann V, et al. Iron-binding characteristics of neuromelanin of the human substantia nigra. Biochem Pharmacol 2003; 66: 489-494.
4. Sasaki M, Shibata E, Tohyama K, et al. Neuromelanin magnetic resonance imaging of locus coeruleus and substantia nigra in Parkinson's disease. NeuroReport 2006; 17: 1215-1218.
5. Sasaki M, Shibata E, Kudo K, Tohyama K. Neuromelanin sensitive MRI. Clin Neuroradiol 2008; 18: 147-153.
6. Kashihara K, Shinya T, Higaki F. Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease. J Clin Neurosci 2011; 18: 1093-1096.
7. Huges AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
8. Nikos Nikolaou NP. Color reduction for complex document images. Int J Imaging Syst Technol 2009; 19: 14-26.
9. Sun X, Zhang H, Duan H. 3D computerized segmentation of lung volume with computed tomography. Acad Radiol 2006; 13: 670-677.
10. Birkmayer W, Birkmayer JD. Dopamine action and disorder of neurotransmitter balance. Gerontology 1987; 33: 168-171.
11. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-2301.
12. Ohtsuka C, Sasaki M, Konno K, et al. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging. Neurosci Lett 2013; 541: 93-98.
13. Berg D. Transcranial sonography in the early and differential diagnosis of Parkinson's disease. J Neural Tansm Suppl 2006; 70: 249-254.
14. Ogisu K, Kudo K, Sasaki M, et al. 3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson's disease. Neuroradiology 2013; 55: 719-724.
15. Schwarz ST, Rittman T, Gontu V, et al. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease. Mov Disord 2011; 26: 1633-1638.
16. Graham JM, Paley MN, Grünewald RA, Hoggard N, Griffiths PD. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 2000; 123: 2423-2431.
17. Enochs WS, Petherick P, Bogdanova A, Mohr U, Weissleder R. Paramagnetic metal scavenging by melanin: MR imaging. Radiology 1997; 204: 417-423.
18. Tosk JM, Holshouser BA, Aloia RC, et al. Effects of the interaction between ferric iron and L-dopa melanin on T1 and T2 relaxation times determined by magnetic resonance imaging. Magn Reson Med 1992; 26: 40-45.